Actively Recruiting
Study of Genetic Causes and Brain Activity in Juvenile Myoclonic Epilepsy Collecting Blood Samples and Clinical Data from Ages 10 to 40
Led by King's College London · Updated on 2025-09-05
1000
Participants Needed
15
Research Sites
26 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying Juvenile Myoclonic Epilepsy JME, a common type of Genetic Generalised Epilepsy that often begins in childhood and affects about 1% of people. The goal is to identify the genetic causes of JME by comparing genetic information from over 1000 people with JME to data from 2000 people without epilepsy. Understanding these genetic factors may help improve treatments and allow earlier detection of JME. Participants diagnosed with JME will provide one blood sample during a single visit, where 10-20ml of blood will be collected to extract DNA for analysis. The study also uses existing control DNA samples from people without seizures. Clinical data and EEG recordings related to each participants diagnosis will be collected and compared to find genetic differences linked to JME. During the study, participants will undergo one blood draw and provide access to clinical data and EEG results. Researchers will analyze the DNA through a genomewide association study and evaluate brainwave patterns with quantitative EEG. The study involves only one visit and no active treatment. Results aim to improve understanding of JME genetics, potentially leading to better tailored treatments in the future.
CONDITIONS
Brief Title
Biology of Juvenile Myoclonic Epilepsy
Research Team
D
Deb K Pal, MD PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here